Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inspecs GroupLSE:SPEC 50 EV-to-OCF is 1,609.56 as of Aug. 02, 2026, which is 14144% above its 10-year median of 11.30. GuruFocus rates LSE:SPEC with a GF Score™ of 50/100 and a GF Value™ of £0.58 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Inspecs Group ranks worse than 99.53% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Inspecs Group's Enterprise Value is £149.7 Mil.
Inspecs Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £0.1 Mil. Therefore, Inspecs Group's EV-to-OCF for today is 1,609.56.
The historical rank and industry rank for Inspecs Group's EV-to-OCF or its related term are showing as below:
LSE:SPEC'
s EV-to-OCF Range Over the Past 10 Years
Min: -608.86 Med: 11.3 Max: 1609.56
Current: 1609.56
During the past 10 years, the highest EV-to-OCF of Inspecs Group was 1609.56. The lowest was -608.86. And the median was 11.30.
LSE:SPEC's EV-to-OCF is ranked worse than 99.53% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.9
vs LSE:SPEC: 1609.56
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspecs Group's PE Ratio (TTM) for today is calculated as:
Inspecs Group's share price for today is £0.97.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Inspecs Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.094.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Inspecs Group EV-to-OCF Related Terms
Inspecs Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Inspecs Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Inspecs Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspecs Group EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Inspecs Group's EV-to-OCF falls into.
Inspecs Group's current Enterprise Value is £149.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Inspecs Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £0.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspecs Group (LSE:SPEC) has a EV-to-OCF of 1,609.56 as of Aug. 02, 2026. This is 14144% above median its historical median of 11.30. According to the industry distribution chart, Inspecs Group ranks #849 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 99.5%.
Is Inspecs Group's EV-to-OCF too high?
Inspecs Group's current EV-to-OCF of 1,609.56 is 14144% above median its 10-year median of 11.30. The Medical Devices & Instruments industry median EV-to-OCF is 7.90. Inspecs Group's value of 1,609.56 is 20274.2% above this industry median. Based on the distribution chart, Inspecs Group ranks #849 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Inspecs Group has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Inspecs Group ranks #849 out of 853 companies for EV-to-OCF. This places Inspecs Group in the lower half of its industry. The industry median EV-to-OCF is 7.90. Inspecs Group's value of 1,609.56 is 20274.2% above this benchmark. While the company's 10-year median is 11.30 vs. the industry median of 7.90, Inspecs Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.90, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspecs Group's current EV-to-OCF of 1,609.56 is 20274.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspecs Group's current EV-to-OCF is 1,609.56, which is 14144% above median its own 10-year median of 11.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Based on GuruFocus' analysis, Inspecs Group (LSE:SPEC) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.58, compared to a current price of £0.97 — trading 67.2% above its estimated fair value. The current EV-to-OCF is 1,609.56, which is 14144% above median its 10-year median of 11.30 and 20274.2% above the Medical Devices & Instruments industry median of 7.90. Inspecs Group's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Inspecs Group (LSE:SPEC), the current EV-to-OCF is 1,609.56 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspecs Group (LSE:SPEC) Overvalued in 2026?
Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued.
The current stock price of £0.97 is trading 67.2% above its estimated GF Value™ of £0.58.
GuruFocus considers Inspecs Group to be Significantly Overvalued.
Key valuation signals for LSE:SPEC:
EV-to-OCF: 1,609.56 (14144% above median its 10-year median of 11.30)
GF Value™: £0.58 vs. price of £0.97 (67.2% above fair value)
Industry Position: 20274.2% above the Medical Devices & Instruments median (#849 of 853)
No single metric tells the full story. See the LSE:SPEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
50GF Score
Get the complete analysis for LSE:SPEC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SPEC has been successfully added to your 
